Skip to main content

Table 1 Treatment Protocol for the Evaluation of Cardiopreventive Effects of Aqueous Leaf Extracts of X. americana and P. capensis in Rats with Myocardial Infarction

From: Evaluation of cardiopreventive effects of Ximenia americana (Linn.) and Pappea capensis (Eckl. and Zeyh.) leaf aqueous extracts in rat models with myocardial infarction

Group

Treatment

I (normal control)

Vehicle (0.9% w/v normal saline)

II (negative control)

Vehicle + 7.5 mg Kg−1 bw−1 Salbutamol

III (positive control)

10 mg Kg−1 bw−1 Propranolol + 7.5 mg Kg−1 bw−1 Salbutamol

IV (experimental A)

50 mg Kg−1 bw−1 Extract + 7.5 mg Kg−1 bw−1 Salbutamol

V (experimental B)

100 mg Kg−1 bw−1 Extract + 7.5 mg Kg−1 bw−1 Salbutamol

VI (experimental C)

150 mg Kg−1 bw−1 Extract + 7.5 mg Kg−1 bw−1 Salbutamol